NO910923D0 - Trifunksjonell antistofflignende forbindelse som et kombinert diagnostisk og terapeutisk middel. - Google Patents
Trifunksjonell antistofflignende forbindelse som et kombinert diagnostisk og terapeutisk middel.Info
- Publication number
- NO910923D0 NO910923D0 NO910923A NO910923A NO910923D0 NO 910923 D0 NO910923 D0 NO 910923D0 NO 910923 A NO910923 A NO 910923A NO 910923 A NO910923 A NO 910923A NO 910923 D0 NO910923 D0 NO 910923D0
- Authority
- NO
- Norway
- Prior art keywords
- therapeutic agent
- similar compound
- trifunctional antibody
- combined diagnostic
- antibody similar
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6875—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody being a hybrid immunoglobulin
- A61K47/6879—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody being a hybrid immunoglobulin the immunoglobulin having two or more different antigen-binding sites, e.g. bispecific or multispecific immunoglobulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
- A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49140690A | 1990-03-09 | 1990-03-09 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO910923D0 true NO910923D0 (no) | 1991-03-08 |
NO910923L NO910923L (no) | 1991-09-10 |
Family
ID=23952086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO91910923A NO910923L (no) | 1990-03-09 | 1991-03-08 | Trifunksjonell antistofflignende forbindelse som et kombinert diagnostisk og terapeutisk middel. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0453082A1 (no) |
JP (1) | JPH0692873A (no) |
AU (1) | AU637202B2 (no) |
CA (1) | CA2037835A1 (no) |
IL (1) | IL97459A0 (no) |
NO (1) | NO910923L (no) |
ZA (1) | ZA911741B (no) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5736122A (en) * | 1991-02-08 | 1998-04-07 | Diatide, Inc. | Technetium-99m labeled peptides for thrombus imaging |
US6019958A (en) * | 1991-02-08 | 2000-02-01 | Diatide, Inc. | Technetium-99m labeled peptides for imaging inflammation |
DE69230525T2 (de) * | 1991-02-08 | 2000-06-21 | Diatide Inc | Technetium-99m markierte Polypeptide zur Bildformung |
US5561220A (en) * | 1991-02-08 | 1996-10-01 | Diatech, Inc. | Technetium-99m labeled peptides for imaging inflammation |
US5443815A (en) * | 1991-11-27 | 1995-08-22 | Diatech, Inc. | Technetium-99m labeled peptides for imaging |
US5552525A (en) * | 1991-02-08 | 1996-09-03 | Diatech Inc. | Technetium-99m labeled peptides for imaging inflammation |
US5645815A (en) | 1991-02-08 | 1997-07-08 | Diatide, Inc. | Radiolabled compounds for thrombus imaging |
AU2400692A (en) * | 1991-07-19 | 1993-02-23 | Hybritech Incorporated | Trifunctional compounds having specificity for multi-drug resistant cells |
US5989519A (en) * | 1992-03-13 | 1999-11-23 | Diatide, Inc. | Technetium-99m labeled peptides for imaging inflammation |
US5508020A (en) * | 1992-06-05 | 1996-04-16 | Diatech, Inc. | Technetium-99M labeled peptides for imaging |
US5968476A (en) * | 1992-05-21 | 1999-10-19 | Diatide, Inc. | Technetium-99m labeled peptides for thrombus imaging |
DK0641222T3 (da) * | 1992-05-21 | 2000-12-11 | Diatide Inc | Peptider mærket med technetium-99m til trombeafbildning |
US6017512A (en) * | 1992-06-23 | 2000-01-25 | Diatide, Inc. | Radiolabeled peptides |
US5620675A (en) | 1992-06-23 | 1997-04-15 | Diatech, Inc. | Radioactive peptides |
US5716596A (en) * | 1992-06-23 | 1998-02-10 | Diatide, Inc. | Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
US5871711A (en) * | 1992-06-23 | 1999-02-16 | Diatide, Inc. | Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
GB9221657D0 (en) * | 1992-10-15 | 1992-11-25 | Scotgen Ltd | Recombinant bispecific antibodies |
GB2286189A (en) * | 1992-10-15 | 1995-08-09 | Scotgen Ltd | Recombinant specific binding protein |
ZA942439B (en) * | 1993-04-08 | 1996-01-08 | Diatech Inc | Radiolabeled compounds for thrombus imaging |
US5951964A (en) * | 1993-06-04 | 1999-09-14 | Diatide, Inc. | Technetium-99m labeled peptides for imaging |
SG48977A1 (en) * | 1993-06-23 | 1998-05-18 | Diatide Inc | Radiolabeled peptides |
GB9314623D0 (en) * | 1993-07-14 | 1993-08-25 | Nordion Int Inc | Localization and therapy with agents directed against prostate specific antigen in breast cancer |
US6051206A (en) * | 1994-06-03 | 2000-04-18 | Diatide, Inc | Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
DK0912612T3 (da) * | 1996-07-25 | 2004-02-02 | Gsf Forschungszentrum Umwelt | Forenklet fremstilling af bispecifikke antistoffragmenter |
WO1999002567A2 (en) * | 1997-07-08 | 1999-01-21 | Board Of Regents, The University Of Texas System | Compositions and methods for producing homoconjugates of antibodies which induce growth arrest or apoptosis of tumor cells |
RU2149023C1 (ru) * | 1998-04-20 | 2000-05-20 | Ерхов Валентин Сергеевич | Способ получения специфической антисыворотки к универсальному опухолевому антигену и способ диагностики злокачественных опухолей с использованием этой антисыворотки |
US9028822B2 (en) | 2002-06-28 | 2015-05-12 | Domantis Limited | Antagonists against TNFR1 and methods of use therefor |
US7696320B2 (en) | 2004-08-24 | 2010-04-13 | Domantis Limited | Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
EP1419786A1 (en) | 2002-11-13 | 2004-05-19 | Bracco Imaging S.p.A. | Method for the selective and quantitative functionalization of immunoglobulin fab fragments, conjugate compounds obtained with the same and compositions thereof |
WO2005118642A2 (en) | 2004-06-01 | 2005-12-15 | Domantis Limited | Bispecific fusion antibodies with enhanced serum half-life |
EP2674440B1 (en) | 2005-12-16 | 2019-07-03 | IBC Pharmaceuticals, Inc. | Multivalent immunoglobulin-based bioactive assemblies |
PL3903829T3 (pl) | 2009-02-13 | 2023-08-14 | Immunomedics, Inc. | Immunokoniugaty z połączeniem rozszczepialnym wewnątrzkomórkowo |
US20160095939A1 (en) | 2014-10-07 | 2016-04-07 | Immunomedics, Inc. | Neoadjuvant use of antibody-drug conjugates |
BR112015013444B1 (pt) | 2012-12-13 | 2022-11-01 | Immunomedics, Inc | Uso de um imunoconjugado |
US9901647B2 (en) | 2013-02-28 | 2018-02-27 | Immunogen, Inc. | Conjugates comprising cell-binding agents and cytotoxic agents |
EP3313443B9 (en) | 2015-06-25 | 2023-10-04 | Immunomedics, Inc. | Combining anti-hla-dr or anti-trop-2 antibodies with microtubule inhibitors, parp inhibitors, bruton kinase inhibitors or phosphoinositide 3-kinase inhibitors significantly improves therapeutic outcome in cancer |
EP3316885B1 (en) | 2015-07-01 | 2021-06-23 | Immunomedics, Inc. | Antibody-sn-38 immunoconjugates with a cl2a linker |
JOP20190100A1 (ar) | 2016-11-19 | 2019-05-01 | Potenza Therapeutics Inc | بروتينات ربط مولد ضد مضاد لـ gitr وطرق استخدامها |
PL3658589T3 (pl) | 2017-07-26 | 2024-03-18 | Forty Seven, Inc. | Przeciwciała anty-sirp-alfa i powiązane sposoby |
JP2021509823A (ja) | 2018-01-04 | 2021-04-08 | アイコニック セラピューティクス インコーポレイテッド | 抗組織因子抗体、抗体薬物コンジュゲート、及び関連する方法 |
IL310662A (en) | 2021-08-23 | 2024-04-01 | Immunitas Therapeutics Inc | Anti-CD161 antibodies and their uses |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4671958A (en) * | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
CA1260827A (en) * | 1984-08-31 | 1989-09-26 | Richard C. Siegel | Antibody-metal ion complexes |
US4722892A (en) * | 1984-08-31 | 1988-02-02 | Meares Claude F | Monoclonal antibodies against metal chelates |
US4659839A (en) * | 1984-10-10 | 1987-04-21 | Mallinckrodt, Inc. | Coupling agents for radiolabeled antibody fragments |
US4831122A (en) * | 1986-01-09 | 1989-05-16 | Regents Of The University Of Minnesota | Radioimmunotoxins |
US4814438A (en) * | 1986-12-24 | 1989-03-21 | Eli Lilly And Company | Immunoglobulin conjugates of 2',2'-difluronucleosides |
IL84842A0 (en) * | 1986-12-24 | 1988-06-30 | Lilly Co Eli | Immunoglobulin conjugates |
US5202451A (en) * | 1988-02-17 | 1993-04-13 | Neorx Corporation | Anchimeric radiometal chelating compounds |
FI105320B (fi) * | 1988-04-04 | 2000-07-31 | Oncogen | Menetelmä vasta-aineheterokonjugaattien valmistamiseksi, joita käytetään imusoluaktiivisuuden säätelyssä ja diagnoosissa |
GB8813527D0 (en) * | 1988-06-08 | 1988-07-13 | Glennie M J | Bispecific antibodies |
GB8824869D0 (en) * | 1988-10-24 | 1988-11-30 | Stevenson G T | Synthetic antibody |
-
1991
- 1991-03-06 IL IL97459A patent/IL97459A0/xx unknown
- 1991-03-07 AU AU72722/91A patent/AU637202B2/en not_active Ceased
- 1991-03-08 EP EP91301948A patent/EP0453082A1/en not_active Withdrawn
- 1991-03-08 JP JP3068823A patent/JPH0692873A/ja active Pending
- 1991-03-08 NO NO91910923A patent/NO910923L/no unknown
- 1991-03-08 CA CA002037835A patent/CA2037835A1/en not_active Abandoned
- 1991-03-08 ZA ZA911741A patent/ZA911741B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IL97459A0 (en) | 1992-06-21 |
EP0453082A1 (en) | 1991-10-23 |
ZA911741B (en) | 1992-11-25 |
CA2037835A1 (en) | 1991-09-10 |
JPH0692873A (ja) | 1994-04-05 |
AU7272291A (en) | 1991-09-12 |
NO910923L (no) | 1991-09-10 |
AU637202B2 (en) | 1993-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO910923L (no) | Trifunksjonell antistofflignende forbindelse som et kombinert diagnostisk og terapeutisk middel. | |
FI910851A (fi) | 3-arylkarbonyl-1h-indoler anvaendbara som terapeutiska aemnen. | |
MX9102473A (es) | Agentes farmaceuticos. | |
DE68914678T2 (de) | Orthese. | |
FI914004A (fi) | Epoxifunktionella siloxanhartskopolymerer som loesgoeringsreglerande tillaeggsaemnen. | |
FI915357A (fi) | Optisk bakskiva som foerbinder kretskort. | |
FI914797A (fi) | Maettade hydroxialkylkinolinsyror som leukotrienantagonister. | |
DE3889062D1 (de) | Monoklonaler Antikörper gegen humanen BCDF. | |
FI912468A (fi) | Oxidantkaensliga och -okaensliga aromatiska estrar som inhibitorer foer humant neutrofilelastas. | |
FI915568A (fi) | Polyamidhartskompositioner foer anvaendning som bindemedel foer laminerande tryckfaergshartser. | |
FI894650A0 (fi) | Antigen, som associerar till en human tumoer. | |
DE68907933T2 (de) | Therapeutisches Mittel für Thrombocytopenia. | |
NO890096D0 (no) | Pyrazol- og indozolpyridinaminer, en fremgangsmaate for fremstilling og anvendelse derav som medikamenter. | |
DE69100165D1 (de) | Aufreissbarer versandsumschlag. | |
FI923486A (fi) | Terapeutiska aemnen. | |
NO893474L (no) | Flammehemmende midler og fremgangsmaate for anvendelse. | |
NO901169L (no) | Azol-1-alkanamider som anti-arrytmiske midler og fremstilling derav. | |
DE59104786D1 (de) | Patientenliegefläche. | |
NO954695D0 (no) | Jod-borforbindelser egnet som röntgenkontrastmidler, og farmasöytiske forbindelser derav | |
TR25921A (tr) | PESTISID ETKINLIGI HAIZ PESTISID ÖZELLIKTE BISIKLOOKTANLAR,BUNLARI IHTIVA EDEN FORMüLASYONLAR VE HAZIRLANMALARINA MAHSUS USULLER. | |
FI910753A0 (fi) | Terapeutiska nukleocider. | |
FR2713479B1 (fr) | Bassin médical. | |
FI923528A (fi) | Terapeutiska aemnen. | |
NO901200L (no) | Azol-1-alkanamider som anti-arrytmiske midler og fremstilling derav. | |
DE69113570D1 (de) | Behandlungsmittel. |